UE LifeSciences and Siemens Healthineers Launch iBreastExam in the U.S.

February 3, 2022

UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers, adding its flagship device iBreastExam to Siemens’ 360-degree breast care product portfolio for the U.S. market. The two organizations unite to improve outcomes for a disease that impacts 1 in 8 women (in the U.S.) during their lifetime; a disease that disproportionately affects Black and Hispanic women and one that is projected to claim the lives of 43,600 women this year.

“We’re committed to improving breast cancer-related outcomes by recognizing unmet needs in healthcare delivery, and UE LifeSciences’ iBreastExam clearly addresses a well-defined niche in primary care,” said Niral Patel, Vice President of X-ray Products for Siemens Healthineers. “With iBreastExam we’re making women’s health more equitable and inclusive for all populations.”